NEW ORLEANS Asthma appeared to be associated with lower mortality in patients admitted to the hospital with myocardial infarction (MI), according to the results of a large propensity-matched cohort study presented at the CHEST 2019 Annual Meeting held October 19 to 23, in New Orleans, Louisiana. Researchers hypothesized that the immunopathology profile associated with asthma might confer protection after MI. All hospital admissions with a primary diagnosis of MI (both ST-elevation MI and non-ST-elevation MI) were examined using the 2016 National Inpatient Sample Continue reading →

HOUSTON--(BUSINESS WIRE)--InGeneron, Inc., a regenerative medicine and cell therapy company, today announced the publication of promising results in developing a novel treatment for chronic ischemic heart failure using its regenerative cell therapy platform. A newly-released research paper published in the World Journal of Stem Cells provides missing pieces of evidence for a fundamental change in the treatment of chronic ischemic heart failure, showing efficacy and safety of a novel stem cell treatment in cardiology. Patients with heart failure as a consequence of previous myocardial infarction are a large and currently underserved patient population, due to the lack of regenerative treatment options Continue reading →

New York, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Biomarkers Testing Market by Type, Application and Location of Testing: Global Opportunity Analysis and Industry Forecast, 20192026" - https://www.reportlinker.com/p05793200/?utm_source=GNW The global cardiac biomarker market generated $7,638 million in 2018, and is projected to reach $18,232 million by 2026, growing at a CAGR of 11.4%. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state as well as for diagnostic and prognostic purposes associated with heart. Continue reading →

Raymond Kwong, director of cardiac magnetic resonance imaging at Brigham and Womens Hospital, associate professor of medicine at Harvard Medical School, and lead investigator of the Stress CMR Perfusion Imaging in the United States (SPINS) study, discusses the high diagnostic and prognostic power of Heart MRIs, as well as their ability to reduce downstream costs for patients. Multiple studies show that heart magnetic resonance imaging (MRI), a modality for non-invasive, non-radiation assessment of the function and structure of the heart and cardiovascular system, is highly accurate in the detection of obstructive coronary stenosis. Continue reading →

A detailed segmentation-wise analysis included in the study highlights key segments of the ICU Equipment Carrier Market, and offers associated market numbers that allude at their growth potential at present as well as in the assessment period. Continue reading →

Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw Continue reading →